These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20155865)

  • 1. Ropinirole diminishes myoclonus and improves writing and postural balance in an ULD patient.
    Karvonen MK; Kaasinen V; Korja M; Marttila RJ
    Mov Disord; 2010 Mar; 25(4):520-1. PubMed ID: 20155865
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A; Gelisse P; Genton P
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological findings in patients with Unverricht-Lundborg disease.
    Ferlazzo E; Gagliano A; Calarese T; Magaudda A; Striano P; Cortese L; Cedro C; Laguitton V; Bramanti P; Carbonaro M; Albachiara A; Fragassi N; Italiano D; Sessa E; Coppola A; Genton P
    Epilepsy Behav; 2009 Mar; 14(3):545-9. PubMed ID: 19185615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S98-102. PubMed ID: 12211149
    [No Abstract]   [Full Text] [Related]  

  • 5. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement-related desynchronization-synchronization (ERD/ERS) in patients with Unverricht-Lundborg disease.
    Visani E; Agazzi P; Canafoglia L; Panzica F; Ciano C; Scaioli V; Avanzini G; Franceschetti S
    Neuroimage; 2006 Oct; 33(1):161-8. PubMed ID: 16904345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficult differential diagnosis of Unverricht-Lundborg disease with spontaneous kinesogenic myoclonus and movement disorder.
    Rana AQ; Ali A; Böke BN
    Acta Neurol Belg; 2012 Dec; 112(4):383-4. PubMed ID: 22539245
    [No Abstract]   [Full Text] [Related]  

  • 10. N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects.
    Edwards MJ; Hargreaves IP; Heales SJ; Jones SJ; Ramachandran V; Bhatia KP; Sisodiya S
    Neurology; 2002 Nov; 59(9):1447-9. PubMed ID: 12427904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic drug intervention decouples electroencephalogram (EEG) signals: a case study in Unverricht-Lundborg Disease.
    Liu CC; Xanthopoulos P; Chaovalitwongse W; Pardalos PM; Uthman BM
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2108-11. PubMed ID: 19163112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perampanel in 12 patients with Unverricht-Lundborg disease.
    Crespel A; Gelisse P; Tang NP; Genton P
    Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure.
    Dibbens LM; Michelucci R; Gambardella A; Andermann F; Rubboli G; Bayly MA; Joensuu T; Vears DF; Franceschetti S; Canafoglia L; Wallace R; Bassuk AG; Power DA; Tassinari CA; Andermann E; Lehesjoki AE; Berkovic SF
    Ann Neurol; 2009 Oct; 66(4):532-6. PubMed ID: 19847901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease.
    Korja M; Ferlazzo E; Soilu-Hänninen M; Magaudda A; Marttila R; Genton P; Parkkola R
    Epilepsy Res; 2010 Jan; 88(1):87-91. PubMed ID: 19896804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report].
    Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R
    Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning in progressive myoclonus epilepsy type 1 (Unverricht-Lundborg Disease, EPM1).
    Äikiä M; Hyppönen J; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2021 Sep; 122():108157. PubMed ID: 34171687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping.
    Berkovic SF; Mazarib A; Walid S; Neufeld MY; Manelis J; Nevo Y; Korczyn AD; Yin J; Xiong L; Pandolfo M; Mulley JC; Wallace RH
    Brain; 2005 Mar; 128(Pt 3):652-8. PubMed ID: 15634728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of the successful treatment of severe myoclonus with Lance-Adams syndrome by add-on perampanel showing long term effects].
    Saito K; Oi K; Inaba A; Kobayashi M; Ikeda A; Wada Y
    Rinsho Shinkeigaku; 2021 Jan; 61(1):18-23. PubMed ID: 33328418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ropinirole (Requip) for restless legs syndrome.
    Med Lett Drugs Ther; 2005 Aug; 47(1214):62-4. PubMed ID: 16052162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.